FDA Approvals

Date Posted
Article Title
12/14/2012
Raxibacumab Approved for Inhalational Anthrax

Neutralizes anthrax toxins, which can kill

12/14/2012
Iclusig Approved for Rare Leukemias

Blocks proteins that spur cancer development

12/10/2012
Zytiga's Use Expanded for Advanced Prostate Cancer

Decreases body's production of testosterone

11/29/2012
Cometriq Approved for Rare Thyroid Cancer

Drug designed to inhibit tumor growth

11/21/2012
11/20/2012
11/15/2012
Drug-Eluting Stent Approved for Peripheral Arterial Disease

Coated hollow tube props open thigh artery

11/7/2012
Xeljanz Approved for Rheumatoid Arthritis

For people who can't take methotrexate

11/5/2012
Xarelto's Approval Expanded

To include people with deep vein thrombosis or pulmonary embolism

10/26/2012
Synribo Approved to Treat Rare Leukemia

If other treatments haven't stopped CML's progression

10/22/2012
Fycompa Approved for Epileptic Seizures

Among people aged 12 and older

10/22/2012
Approval Expanded for Sapien Artificial Heart Valve

More people with narrowed aortic valve are now eligible

10/18/2012
Jetrea Approved to Treat Eye Condition

Symptomatic vitreomacular adhesion

10/12/2012
Abraxane Approved to Treat Advanced Lung Cancer

Among people who aren't candidates for surgery or radiation

9/28/2012
New Defibrillator Implanted Just Under the Skin

But it's still designed to correct an irregular heartbeat

9/28/2012
Humira's Approval Widened to Include Ulcerative Colitis

Disease causes inflammation in large intestine

9/27/2012
Stivarga Approved for Advanced Colorectal Cancer

Designed to block enzymes that encourage tumor growth

9/18/2012
First Ultrasound to Spot Cancer in Dense Breasts Approved

Mammography will help doctors decide which women should get new screen

9/13/2012
Aubagio Approved for Multiple Sclerosis

But label warns of possible liver problems, birth defects

9/12/2012
Newly Approved Imaging Agent Helps Find Prostate Cancer

But not replacement for actual tissue testing, FDA says